IschemiRs: MicroRNAs in Ischemic Stroke

Dr Rajanikant G. K. is currently working as a Professor at the School of Biotechnology, and served as the Coordinator of DBT - Bioinformatics Infrastructure Facility at National Institute of Technology Calicut, Calicut, India. Having done his Ph. D. in Radiation Biology & Toxicology from Division of Radiobiology & Toxicology, Manipal University, Manipal, India, he was also awarded a Senior Research Fellowship from Indian Council of Medical Research, Government of India, New Delhi, for the year 2001- 2004. Till date, Dr Rajanikant has worked as a Principal Investigator in various Government funded research projects, and has further guided and supervised several Doctorate and Post- Doctorate students and researchers. He has also successfully applied for an Indian Patent in the year 2017 for using a pharmaceutical composition consisting of 1,4-DI(1H-benzimidazol-2-YL)-1,2,3,4-butanetetrol (BTT) as an ischemic neuroprotectant. He has also been invited as a speaker to various prestigious conferences, and has himself conducted many conferences, workshops and seminars successfully. Dr Rajanikant has several articles in renowned national and international journals, as well as, book chapters and edited volumes, to his credit.
Dr Pierre Gressens is presently holding several prominent positions, including- a Research Officer (DR1 Inserm) and Director, UMR 1141 Inserm-Paris University, Robert-Debré Hospital, Paris, France; Professor of Fetal and Neonatal Neurology, KCL, London, UK; Consultant, Service of Pediatric Neurology, Robert-Debré Hospital, Paris, France; Director, PremUP Foundation, Paris; Coordinator of the University-Hospital Department PROTECT, Robert Debré Hospital, Paris; and Vice-Dean for Research, Paris-Diderot Medical school, Paris, France. He obtained his M.D. and Ph.D. degrees from University of Louvain Medical School at Brussels, Belgium. He has received various honors, such as, Roger de Spoelberch award for neurosciences (Switzerland) in 2010, FRM